Primary Cardiac T-Cell Lymphoma Localized in the Mitral Valve

Motomatsu, Yuma; Oishi, Yoshifumi; Matsunaga, Shogo; Onitsuka, H; Yamamoto, Hidetaka; Zaitsu, Eiko; Yamada, Yuichi; Kohashi, Kenichi; Tominaga, Ryuji

doi:10.1016/j.athoracsur.2015.08.091

Cited by 5 publications

(6 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A malignant lymphoma usually involves the heart as focal masses and diffuse pattern as in this case are uncommon [5]. In a few papers, right atrium was listed as the most common site for cardiac involvement [5,6] but the reason is unknown and it might be due to lymph drainage path through thoracic duct into superior vena cava and subsequently into right atrium [6]. Sometimes tumor spreads from myocardium to the adjacent region, encasing aorta, coronary arteries, and pulmonary artery causing a compression effect on these structures [7].…”

Section: Discussionmentioning

confidence: 92%

Malignant lymphoma with diffuse cardiac involvement and pulmonary stenosis

Alimi

Poorzand

Jafarian

2021

Journal of Cardiology Cases

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 92%

Malignant lymphoma with diffuse cardiac involvement and pulmonary stenosis

Alimi

Poorzand

Jafarian

2021

Journal of Cardiology Cases

View full text Add to dashboard Cite

“…These tumors generally involve the right heart and the right atrium is the cardiac chamber most affected by primary cardiac lymphoma [ 3 ] . Lymphoma may appear isolated in the mitral valve [ 23 ] . In our cases, one of them arose from the right atrium and ventricle, and the other originated from the superior vena cava.…”

Section: Discussionmentioning

confidence: 99%

Outcomes After Surgical Resection of Primary Non-Myxoma Cardiac Tumors

Boyacıoğlu

Dönmez

et al. 2018

Braz J Cardiovasc Surg

View full text Add to dashboard Cite

ObjectivePrimary cardiac tumors are rare lesions with different histological type. We reviewed our 17 years of experience in the surgical treatment and clinical results of primary non-myxoma cardiac tumors.MethodsBetween July 2000 and February 2017, 21 patients with primary cardiac tumor were surgically treated in our institution. The tumors were categorized as benign non-myxomas and malignants. Data including the demographic characteristics, details of the tumor histology and grading, cardiac medical and surgical history, surgical procedure of the patients were obtained from the hospital database.ResultsEleven patients were diagnosed with benign non-myxoma tumor (male/female:7/4), ranging in age from 10 days to 74 years (mean age 30.9±26.5 years). Papillary ﬁbroelastoma was the most frequent type (63.6%). There were two early deaths in benign group (all were rhabdomyoma), and mortality rate was 18%. The mean follow-up period was 69.3±58.7 months (range, 3 to 178 months). All survivals in benign group were free of tumor-related symptoms and tumor relapses. Ten patients were diagnosed with malignant tumor (sarcoma/lymphoma:8/2, male/female:3/7), ranging in age from 14 years to 73 years (mean age 44.7±18.9 years). Total resection could be done in only three (30%) patients. The mean follow-up period was 18.7±24.8 months (range, 0-78 months). Six patients died in the first 10 months.ConclusionComplete resection of the cardiac tumors, whenever possible, is the main goal of surgery. Surgical resection of benign cardiac tumors is safe, usually curative and provides excellent long-term prognosis. On the contrary, malignant cardiac tumors still remain highly lethal.

show abstract

“…There are rare reports of primary cardiac T-cell lymphoma since 1949 and even more rare reports in an immunocompetent patient. 6 , 14 , 15 In 1 case a 70-year-old woman presented with cardiac tamponade with a 500 mL pericardial effusion and subsequently developed complete AV block and torsades de pointes. There was recovery of conduction with CHOP chemotherapy.…”

Section: Discussionmentioning

confidence: 99%